Health Care & Life Sciences » Health System » Medicare | Medicare Part B cancer drugs sales price per dosage U.S. 2014

Top cancer drugs paid by Medicare Part B by sales price per dosage 2014

Leading Medicare Part B cancer drugs based on average sales price per dosage in 2014 (in USD)

The data shows the leading Medicare Part B cancer drugs based on average sales price per dosage in 2014, in USD. The average sales price for one dose (1 mg) of a Denosumab injection totaled 14.45 USD. The size and demographic of medical professionals in oncology plays a significant role in the accessibility and quality of cancer care for patients in the U.S.

Pegfilgrastim injection (6mg) 3387.93
Aflibercept injection (0.1mg) 980.5
Rituximab injection (100mg) 708.68
Ranibizumab injection (0.1mg) 396.43
Trastuzumab injection (10mg) 82.49
Infliximab injection (10mg) 74.34
Bevacizumab injection (10mg) 66.65
Pemetrexed injection (10mg) 60.27
Bortezomib injection (0.1mg) 46.08
Denosumab injection (1mg) 14.45

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.